Meconium Aspiration Syndrome
Definition And Epidemiology
- Meconium aspiration syndrome (MAS) refers to respiratory distress in neonates born through meconium-stained amniotic fluid (MSAF).
- MSAF complicates approximately 10% to 15% of all deliveries.
- About 5% of neonates exposed to MSAF develop MAS in developed countries.
- In developing countries, the incidence of MAS is much higher, ranging from 11% to 28%.
Risk Factors
| Maternal Factors | Fetal And Intrapartum Factors |
|---|---|
| Advanced gestation (post-term pregnancies) | Intrauterine growth restriction |
| Oligohydramnios | Fetal distress or perinatal asphyxia |
| Maternal hypertension or preeclampsia | Thick meconium consistency |
Pathophysiology
- Fetal stress due to hypoxia and acidosis triggers a vagal response.
- This response causes increased intestinal peristalsis and anal sphincter relaxation, leading to meconium passage in utero.
- Fetal gasping efforts result in the aspiration of meconium into the airways.
- Aspirated meconium causes respiratory distress through three main mechanisms.
- Airway obstruction: Complete obstruction of airways results in distal atelectasis. Partial obstruction creates a ball-valve effect, which leads to localized hyperinflation and air leaks.
- Surfactant inactivation: Fatty acids in the meconium cause atelectasis and worsen the ventilation-perfusion mismatch. Meconium also damages the alveolar-capillary membrane and reduces surfactant proteins.
- Chemical pneumonitis: Meconium triggers the release of cytokines and activates the complement cascade. This inflammatory response can begin antenatally and progress after birth.
- Persistent pulmonary hypertension of the newborn (PPHN): Hypoxia, hypercapnia, and acidosis induce profound pulmonary vasoconstriction. This complicates 15% to 20% of MAS cases and creates a vicious cycle of severe hypoxemia.
Clinical Features And Diagnosis
- Neonates typically present with respiratory distress within the first 2 hours of life.
- Symptoms include tachypnea, hypoxia, and an overinflated, barrel-like chest.
Diagnostic Investigations
| Modality | Key Findings And Utility |
|---|---|
| Chest X-ray | Shows bilateral diffuse patchy infiltrates alternating with areas of hyperinflation. Helps identify air leaks like pneumothorax or pneumomediastinum. |
| Arterial Blood Gas | Demonstrates hypoxemia, hypercarbia, and respiratory or metabolic acidosis. |
| Echocardiography | Essential for neonates requiring high oxygen to diagnose co-existing PPHN or myocardial dysfunction. |
| Lung Ultrasound | Provides good accuracy for rapid bedside diagnosis of air leaks. |
Management
Delivery Room Management
- Routine oropharyngeal and nasopharyngeal suctioning on the perineum is no longer recommended.
- Routine endotracheal intubation for suctioning meconium is not recommended, even in non-vigorous neonates.
- The primary emphasis must be on providing adequate ventilation and oxygenation.
- If the infant does not improve with positive-pressure ventilation, the trachea may be suctioned using a catheter inserted through the endotracheal tube.
Respiratory Support
- Neonates must be transferred to the neonatal intensive care unit (NICU) for close monitoring.
- Target preductal oxygen saturation is strictly maintained between 92% and 95%.
- Continuous positive airway pressure (CPAP): Indicated for moderate distress or an oxygen requirement exceeding 40%. Initial pressures of 5 cm H2O are used. Pneumothorax must be ruled out prior to CPAP initiation.
- Mechanical ventilation: Indicated for CPAP failure or respiratory acidosis (pH <7.25 and pCO2 >60 mmHg).
- Overinflated lungs require lower positive end-expiratory pressure (PEEP) to avoid air trapping.
- High-frequency ventilation (HFV) is utilized if mean airway pressures are high or as a precursor to nitric oxide therapy.
Pharmacological And Adjuvant Therapies
- Surfactant replacement: Exogenous surfactant improves oxygenation and decreases the need for extracorporeal membrane oxygenation (ECMO). It is recommended for severe MAS requiring invasive ventilation.
- Inhaled nitric oxide (iNO): The treatment of choice for severe PPHN complicating MAS. It is initiated at 20 parts per million when the oxygenation index reaches 15 to 25.
- Antibiotics: Routine administration is not indicated. They are reserved for neonates with identified risk factors for sepsis or a clinical course suggestive of infection.
- ECMO: Utilized as a life-saving rescue therapy for neonates with refractory hypoxemic respiratory failure who fail conventional ventilation and iNO.